ArticlePloS one2016

Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.

Spencer D Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.